drugset / Trial / NCT00282971

A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus

NCT00282971

Phase 3 Terminated 354 enrolled Pfizer
RandomizedParallel-groupOpen-labelTreatment

Summary

To assess the impact on glucose control by inhaled insulin in patients with type 2 diabetes who are not well controlled on 2 or more oral anti-diabetic agents

Timeline

Start
2006-03-06
Primary completion
2008-02-19
Completion
2008-02-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic Inhaled